Combined Treatment of Resistant Hypertension and Atrial Fibrillation

Clinical trial NCT01117025 · COMPLETED

Trial details

NCT number: NCT01117025
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension, Resistant to Conventional Therapy Atrial Fibrillation

Start date: 2010-04-01
Primary completion: 2011-08-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.